On 11 January 2012, orphan designation (EU/3/11/944) was granted by the European Commission to CTI Science Limited, Ireland, for N,N'-bis(2-mercaptoethyl)isophthalamide for the treatment of mercury toxicity.
In July 2015, CTI Science Limited changed name to NBMI Science Limited.
This medicine is now known as emeramide.
Treatment of mercury toxicity
|Orphan designation status||
|EU designation number||
|Date of designation||
Review of designation
Documents related to this orphan designation evaluation
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
EU register of orphan medicines
The list of medicines that have received an orphan designation in the EU is available on the European Commission's website: